tiprankstipranks
Eledon Pharmaceuticals reports Q3 EPS (73c), consensus (68c)
The Fly

Eledon Pharmaceuticals reports Q3 EPS (73c), consensus (68c)

The company had approximately $65.9 million in cash and cash equivalents as of September 30 , compared to $84.8 million in cash and cash equivalents as of December 31, 2021. The company believes that it has sufficient financial resources to fund operating activities into 2024.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on ELDN:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles